Atossa Therapeutics ATOS
NASDAQ ATOS
$2.34 +0.07 (+3.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Gains from Sales and Divestitures (2015 - 2024)

Updated

Atossa Therapeutics (ATOS) posted Gains from Sales and Divestitures of -$4,000 for Q4 2024.

Analysis

Atossa Therapeutics (ATOS) Gains from Sales and Divestitures (2015 - 2024) Analysis & Trends

For FY2024, Atossa Therapeutics' Gains from Sales and Divestitures came in at -$7,000.

  • In prior years, Atossa Therapeutics' Gains from Sales and Divestitures was -$3,000 in FY2022 and -$32,000 in FY2020.
  • The Q4 2024 figure stands as the lowest quarterly Gains from Sales and Divestitures since Q4 2020.
  • According to Business Quant data, Gains from Sales and Divestitures for the three prior quarters was $1,000 (Q3 2024), -$2,000 (Q2 2024) and -$2,000 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Atossa Therapeutics 23.35 Mn 23.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4,000.00
Sep 30, 2024 1,000.00
Jun 30, 2024 -2,000.00
Mar 31, 2024 -2,000.00
Sep 30, 2022 -2,000.00
Dec 31, 2020 -27,851.00
Sep 30, 2020 -1,923.00
Dec 31, 2017 -35,390.00
Mar 31, 2017 -17,695.00
Mar 31, 2016 -163,333.00
Sep 30, 2015 81,333.00
Jun 30, 2015 -6,533.00
API Access

Atossa Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ATOS&period=max&api_key=YOUR_API_KEY